HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
📊 HOLD: HSIC is fairly valued with market pricing in 2.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, HSIC is in a downtrend. The price is approaching resistance at $80.83. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HSIC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Protect Your Profits
HSIC is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($88.07)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
Trading Range Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is HSIC showing a specific setup today?
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$941 | 60 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$351 | 64 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$245 | 62 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.